Night Blindness, Congenital Stationary, Type 1e; Csnb1e
Description
Complete congenital stationary night blindness (cCSNB) is a clinically and genetically heterogeneous group of retinal disorders characterized by nonprogressive impairment of night vision, absence of the electroretinogram (ERG) b-wave, and variable degrees of involvement of other visual functions. Individuals with cCSNB and animal models of the disorder have an ERG waveform that lacks the b-wave because of failure to transmit the photoreceptor signal through the retinal depolarizing bipolar cells (summary by Peachey et al., 2012).For a general phenotypic description and a discussion of genetic heterogeneity of congenital stationary night blindness, see CSNB1A (OMIM ).
Genes related to Night Blindness, Congenital Stationary, Type 1e; Csnb1e
- GPR179
Clinical Features
Phenotypes and symptoms related to Night Blindness, Congenital Stationary, Type 1e; Csnb1e
- Nystagmus
- Strabismus
- Myopia
- Blindness
- Reduced visual acuity
- Nyctalopia
- Congenital nystagmus
- Congenital stationary night blindness
- Rotary nystagmus
- Complete congenital stationary night blindness
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Night Blindness, Congenital Stationary, Type 1e; Csnb1e Is also known as csnb, complete, autosomal recessive.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Night Blindness, Congenital Stationary, Type 1e; Csnb1e Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Congenital Stationary Night Blindness Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RHO, GRK1, SAG, SLC24A1, CABP4, CACNA1F, LRIT3, GPR179, GNAT1, GNB3, GRM6, TRPM1, NYX, PDE6B, RDH5
Specificity
7 %
Genes
100 % |
GPR179 mutation analysis.
By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam (Netherlands).
GPR179
Specificity
100 %
Genes
100 % |
Night blindness, congenital stationary 1E, AR (sequence analysis of GPR179 gene).
By CGC Genetics (Portugal).
GPR179
Specificity
100 %
Genes
100 % |
Night blindness, congenital stationary (NGS panel of 13 genes).
By CGC Genetics (Portugal).
RHO, GRK1, SAG, SLC24A1, CACNA1F, LRIT3, GPR179, GNAT1, GNB3, GRM6, TRPM1, NYX, PDE6B
Specificity
8 %
Genes
100 % |
Night blindness, congenital stationary (NGS panel of 13 genes).
By CGC Genetics (Portugal).
RHO, GRK1, SAG, SLC24A1, CACNA1F, LRIT3, GPR179, GNAT1, GNB3, GRM6, TRPM1, NYX, PDE6B
Specificity
8 %
Genes
100 % |
Congenital Stationary Night Blindness Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
RHO, GRK1, RPE65, SAG, SLC24A1, CABP4, CACNA1F, CHM, CACNA2D4, LRIT3, GPR179, GNAT1, GRM6, TRPM1, NYX, PDE6B, RDH5
Specificity
6 %
Genes
100 % |
Comprehensive Inherited Retinal Dystrophies (includes RPGR ORF15) Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
RGS9, RHO, GRK1, RLBP1, ROM1, RP1, RP2, RP9, RPE65, RPGR, RS1, CNNM4, SAG, SDCCAG8, SEMA4A, SLC24A1, SLC4A7, SPP2, PLK4, TEAD1 , (...)
View the complete list with 286 more genes
Specificity
1 %
Genes
100 % |
Night blindness, congenital stationary, type 1E.
By Centogene AG - the Rare Disease Company (Germany).
GPR179
Specificity
100 %
Genes
100 % |
You can get up to 16 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MASP2 DEFICIENCY ESOPHAGEAL CANCER MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY; MEHMO EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2 MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS SIALURIA BLAU SYNDROME